Lower back pain affects millions of people every year. About 80% of people will experience back pain at some point in their ...

On January 30, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid ...

Spine injections should not be given to adults with chronic back pain because they provide little or no pain relief vs. sham ...

Life with chronic pain is a tough road and affects millions worldwide. Chronic discomfort can interfere with every activity ...

Spine injections should not be given to adults with chronic back pain because they provide little or no pain relief compared ...

Capsaicin preparations have been investigated for the treatment of some facial pain syndromes and of rhinitis with promising preliminary results, Reddy says. So if you have the taste (and stomach ...

It works by switching off nociceptors in the peripheral nervous system, and therefore preventing pain signals getting to the ...

Can be done at home. Cons: Costly. Must be used indefinitely. Evidence of efficacy is mixed. Cost: For at-home treatment, a one-time cost of $500 to $3,000 for the apparatus. What it is: A ...

Read on to learn more about some of the possible causes of pain around the shoulder blades, as well as the treatment options and preventive measures available. There are several potential bone or ...

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller to win FDA approval in more than 20 years.